切换至 "中华医学电子期刊资源库"

中华关节外科杂志(电子版) ›› 2019, Vol. 13 ›› Issue (04) : 443 -447. doi: 10.3877/cma.j.issn.1674-134X.2019.04.010

所属专题: 文献

综述

血小板抗感染的机制研究进展
张昭远1, 杨帆1, 卢年芳2, 袁霆1, 张长青1,()   
  1. 1. 200233 上海交通大学附属第六人民医院骨科
    2. 100073 北京电力医院重症医学科
  • 收稿日期:2018-10-22 出版日期:2019-08-01
  • 通信作者: 张长青
  • 基金资助:
    国家自然科学基金(81572239); 上海申康医院发展中心临床科技创新项目(SHDC12016219)

Research progress of anti-infective mechanism of platelets

Zhaoyuan Zhang1, Fan Yang1, Nianfang Lu2, Ting Yuan1, Changqing Zhang1,()   

  1. 1. Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China
    2. Intensive Care Unit, Beijing Electric Power Hospital, Beijing 100073, China
  • Received:2018-10-22 Published:2019-08-01
  • Corresponding author: Changqing Zhang
  • About author:
    Corresponding author: Zhang Changqing, Email:
引用本文:

张昭远, 杨帆, 卢年芳, 袁霆, 张长青. 血小板抗感染的机制研究进展[J]. 中华关节外科杂志(电子版), 2019, 13(04): 443-447.

Zhaoyuan Zhang, Fan Yang, Nianfang Lu, Ting Yuan, Changqing Zhang. Research progress of anti-infective mechanism of platelets[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2019, 13(04): 443-447.

感染是影响人类健康的常见疾病之一,可造成创面不愈合、脓毒症及其他感染性疾病,继而引发多系统器官衰竭而导致死亡。血小板是最常见的血液成分之一,最先发现内皮细胞损伤和病原微生物入侵并产生反应,可内吞病原体、释放抗菌肽和调节机体的免疫反应等。本文就血小板的抗感染机制研究进展作一综述。

Infection is one of the most common diseases, which can cause nonhealing wound, sepsis and other infectious diseases, then lead to multisystem organ failure and death. Platelets, one of the most common element of blood, is the first component which detect damage of endothelial cell and invasion of pathogen. In addition, platelets can internalize pathogens, secrete antimicrobial peptides, participate in and orchestrate the immune response. In this article, the research progress of anti-infective mechanism of platelets is reviewed.

图2 血小板在白细胞抗感染中的作用机制示意图。血小板通过P-selectin(选择素)与白细胞表面的PSGL-1(P选择素糖蛋白配法)结合,从而粘附于白细胞,形成花环样结构,并释放IL(白介素)-1、β-TG(血小板球蛋白)、PAF(血小板活化因子)等激活白细胞。白细胞被激活后,可吞噬病原体、产生脱颗粒效应(释放超氧化物和溶酶体酶,清除侵入体内的病原微生物)和形成NETs(中性粒细胞胞外诱捕网)
[1]
Yuan T, Zhang CQ, Tang MJ, et al. Autologous platelet-rich plasma enhances healing of chronic wounds[J]. Wounds, 2009, 21(10): 280-285.
[2]
Singh R, Dhayal RK, Sehgal PK, et al. To evaluate antimicrobial properties of platelet rich plasma and source of colonization in pressure ulcers in spinal injury patients[J]. Ulcers, 2015, (2015)1-7.
[3]
Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality?[J]. J Clin Invest, 2016, 126(1): 23-31.
[4]
Gotts Jeffrey E, Matthay Michael A. Sepsis: pathophysiology and clinical management[J/OL]. BMJ,2016,353:i1585. doi: 10.1136/bmj.i1585.
[5]
Claushuis TA, Van Vught LA, Scicluna BP, et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients[J]. Blood, 2016, 127(24): 3062-3072.
[6]
Deppermann C, Kubes P. Platelets and infection[J]. Semin Immunol, 2016, 28(6): 536-545.
[7]
Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation[J]. J Interferon Cytokine Res. 2002, 22(9): 913-922.
[8]
Youssefian T, Drouin A, Masse JM, et al. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation[J]. Blood, 2002, 99(11): 4021-4029.
[9]
Danon D, Jerushalmy Z, Devries A. Incorporation of influenze virus in human blood platelets invitro-electron microscopical observation[J]. Virology, 1959, 9(4): 719-722.
[10]
Hamzeh-Cognasse H, Damien P, Chabert AA, et al. Platelets and infections--complex interactions with bacteria[J/OL]. Front Immunol, 2015, 6: 82.doi: 10.3389/fimmu.2015.00082
[11]
Huang ZY, Chien P, Indik ZK, et al. Human platelet FcγRIIA and phagocytes in immune-complex clearance[J]. Mol Immunol, 2011, 48(4): 691-696.
[12]
Worth RG, Chien CD, Chien P, et al. Platelet FcγRIIA binds and internalizes IgG-containing complexes[J]. Exp Hematol, 2006, 34(11): 1490-1495.
[13]
Ali RA, Wuescher LM, Dona KR, et al. Platelets mediate host defense against staphylococcus aureus through direct bactericidal activity and by enhancing macrophage activities[J]. J Immunol, 2017, 198(1): 344-351.
[14]
Yeaman MR, Tang YQ, Shen AJ, et al. Purification and in vitro activities of rabbit platelet microbicidal proteins[J]. Infect Immun, 1997, 65(3): 1023-1031.
[15]
Clawson CC, White JG. Platelet interaction with bacteria.I.Reaction phases and effects of inhibitors[J]. Am J Pathol, 1971, 65(2): 367-380.
[16]
Ivanov IB, Gritsenko VA, Kuzmin MD. The effect of brief exposure to sub-therapeutic concentrations of chlorhexidine digluconate on the susceptibility of staphylococci to platelet microbicidal protein[J]. Surg Infect (Larchmt), 2015, 16(3):263-266.
[17]
Yeaman MR, Ibrahim AS, Jr JE, et al. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro[J]. Antimicrob Agents Chemother, 1993, 37(3): 546-553.
[18]
Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets[J]. Infect Immun, 2002, 70(12): 6524-6533.
[19]
Deuel TF, Senior RM, Huang JS. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor.[J].J Clin Invest, 1982, 69(4): 1046-1049.
[20]
Miron RJ, Fujioka-Kobayashi M, Bishara M, et al. Platelet-rich fibrin and soft tissue wound healing: a systematic review[J]. Tissue Eng Part B Rev, 2017, 23(1): 83-99.
[21]
Anitua E, Aguirre JJ, Algorta J, et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers[J]. J Biomed Mater Res B Appl Biomater, 2008, 84B(2): 415-421.
[22]
Mariani E, Canella V, Berlingeri A, et al. Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro[J]. BMC Microbiol, 2015, 15(1): 149-161.
[23]
Deuel TF, Senior RM, Chang D, et al. Platelet factor 4 is chemotactic for neutrophils and monocytes[J]. Proc Natl Acad Sci USA, 1981, 78(7): 4584-4587.
[24]
Scheuerer B, Ernst M, Dürrbaum-Landmann I, et al. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages[J]. Blood, 2000, 95(4): 1158-1166.
[25]
Criswell KA, Breider MA, Bleavins MR. EDTA-dependent platelet phagocytosis acytochemical, ultrastructural,and functional characterization[J]. Am J Clin Pathol, 2001, 115(3): 376-384.
[26]
李海鹏,姚建华.中性粒细胞在炎症反应中的作用及机制[J].医学综述,2015,21(9):1576-1578.
[27]
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nat Immunol, 2010, 11(5): 373-384.
[28]
Garraud O, Cognasse F. Are platelets cells?And if yes,are they immune cells?[J/OL].Front Immunol,6:70. doi:10.3389/fimmu.2015.00070.
[29]
Cognasse F, Hameh-Cognasse H, Lafarge SA, et al. Human platelets can activate peripheral blood B cells and increase production of immunoglobulins[J]. Exp Hematol, 2007, 35(9): 1376-1387.
[30]
Peerschke EI, Yin W, Ghebrehiwet B. Complement activation on platelets:implications for vascular inflammation and thrombosis[J]. Mol Immunol, 2010, 47(13, SI): 2170-2175.
[31]
Blair P, Flaumenhaft R. Platelet alpha-granules:basic biology and clinical correlates[J]. Blood Rev, 2009, 23(4): 177-189.
[32]
Semple JW, Italiano J, Freedman J. Platelets and the immune continuum[J]. Nat Rev Immunol, 2011, 11(4): 264-274.
[33]
李明,章军辉,李淑敏,等.应用自体富血小板血浆治疗慢性难愈性创面的实验研究[J/CD].中华关节外科杂志(电子版),2016,10(6):624-629.
[1] 武壮壮, 张晓娟, 史泽洪, 史瑶, 原韶玲. 超声联合乳腺X线摄影及PR、Her-2预测高级别与中低级别乳腺导管原位癌的价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 631-635.
[2] 夏传龙, 迟健, 丛强, 连杰, 崔峻, 陈彦玲. 富血小板血浆联合关节镜治疗半月板损伤的临床疗效[J]. 中华关节外科杂志(电子版), 2023, 17(06): 877-881.
[3] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[4] 钱龙, 陆晓峰, 王行舟, 杜峻峰, 沈晓菲, 管文贤. 神经系统调控胃肠道肿瘤免疫应答研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 86-89.
[5] 杨瑞洲, 李国栋, 吴向阳. 腹股沟疝术后感染的治疗方法探讨[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 715-719.
[6] 徐金林, 陈征. 抗菌药物临床应用监测对腹股沟疝修补术预防用药及感染的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 720-723.
[7] 李静如, 王江玲, 吴向阳. 简易负压引流在腹股沟疝术后浅部感染中的疗效分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 745-749.
[8] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[9] 卓徐鹏, 刘颖, 任菁菁. 感染性疾病与老年人低蛋白血症的相关性研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 896-899.
[10] 李静静, 翟蕾, 赵海平, 郑波. 多囊肾合并囊肿的多重耐药菌感染一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 920-923.
[11] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[12] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
[13] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
[14] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
[15] 杨艳丽, 陈昱, 赵若辰, 杜伟, 马海娟, 许珂, 张莉芸. 系统性红斑狼疮合并血流感染的危险因素及细菌学分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 694-699.
阅读次数
全文


摘要